BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36155359)

  • 1. Outcomes for recurrent oral cavity squamous cell carcinoma.
    Contrera KJ; Zafereo ME; Yaniv D; Roberts DB; Gillenwater AM; Hanna EY; Weber RS; Myers JN; Chang EI; Garvey PB; Hanasono MM; Yu P; Hutcheson KA; Fuller CD; Tyler MA; Neskey DM
    Oral Oncol; 2022 Nov; 134():106127. PubMed ID: 36155359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of survival in advanced oral cancers after salvage surgery with free tissue flap reconstruction.
    Hafström A; Wahlberg P; Klasson S; Greiff L; Sjövall J
    Eur Arch Otorhinolaryngol; 2023 Jun; 280(6):2953-2964. PubMed ID: 36897366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimating Survival After Salvage Surgery for Recurrent Oral Cavity Cancer.
    Tam S; Araslanova R; Low TH; Warner A; Yoo J; Fung K; MacNeil SD; Palma DA; Nichols AC
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):685-690. PubMed ID: 28448645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome and prognostic factors in recurrent oral squamous cell carcinoma after primary surgical treatment: a retrospective study.
    Zittel S; Moratin J; Horn D; Metzger K; Ristow O; Engel M; Mrosek J; Freier K; Hoffmann J; Freudlsperger C
    Clin Oral Investig; 2022 Feb; 26(2):2055-2064. PubMed ID: 34581884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
    Matoscevic K; Graf N; Pezier TF; Huber GF
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes of salvage surgery and immune checkpoint inhibitor therapy in recurrent head and neck squamous cell carcinoma: A single-institution retrospective study.
    Konuthula N; Do OA; Gobillot T; Rodriguez CP; Futran ND; Houlton J; Barber BR
    Head Neck; 2022 Nov; 44(11):2465-2472. PubMed ID: 35930296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors and outcomes for salvage surgery in patients with recurrent squamous cell carcinoma of the tongue.
    Goto M; Hanai N; Ozawa T; Hirakawa H; Suzuki H; Hyodo I; Kodaira T; Ogawa T; Fujimoto Y; Terada A; Kato H; Hasegawa Y
    Asia Pac J Clin Oncol; 2016 Mar; 12(1):e141-8. PubMed ID: 23909955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage of Recurrence after Surgery and Adjuvant Therapy: A Multi-institutional Study.
    Zenga J; Graboyes E; Janz T; Drake V; Rettig E; Desai S; Nickel C; Shabani S; Padhya T; Scarpinato M; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
    Otolaryngol Head Neck Surg; 2019 Jul; 161(1):74-81. PubMed ID: 30753110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
    Hosni A; Huang SH; Chiu K; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; Yu E; de Almeida JR; Monteiro E; Chepeha DB; Irish JC; Goldstein DP; Hope A
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):363-373. PubMed ID: 30244160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Salvage Therapy for Oropharyngeal Cancer Recurrence Following Upfront Radiation Therapy and Prognostic Factors.
    Choi N; Kim HJ; Yi H; Kim H; Kim TH; Jeong HS; Son YI; Baek CH; Oh D; Ahn YC; Chung MK
    Cancer Res Treat; 2023 Oct; 55(4):1123-1133. PubMed ID: 37157954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative prediction model to evaluate salvage surgery in patients with recurrent or second primary oral cavity squamous cell carcinoma.
    Lu HJ; Peng CY; Tseng HC; Hsin CH; Chuang CY; Chen CC; Huang WS; Chiu YW; Yang SF
    Oral Oncol; 2022 Aug; 131():105951. PubMed ID: 35728414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irradiation for locoregionally recurrent, never-irradiated oral cavity cancers.
    Lok BH; Chin C; Riaz N; Ho F; Hu M; Hong JC; Shi W; Zhang Z; Sherman E; Wong RJ; Morris LG; Ganly I; Wolden SL; Rao SS; Lee NY
    Head Neck; 2015 Nov; 37(11):1633-41. PubMed ID: 24954094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma.
    Chen TC; Lo TH; Huang HC; Wang CW; Yang TL; Lou PJ; Ko JY; Wang CP
    Head Neck; 2021 Dec; 43(12):3764-3774. PubMed ID: 34510614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity.
    Schwartz GJ; Mehta RH; Wenig BL; Shaligram C; Portugal LG
    Head Neck; 2000 Jan; 22(1):34-41. PubMed ID: 10585603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
    Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
    Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
    Sambasivan K; Sassoon I; Thavaraj S; Kennedy R; Doss G; Michaelidou A; Odell E; Sandison A; Hall G; Morgan P; Collins LHC; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Petkar I; Reis Ferreira M; Kong A; Lei M; Guerrero Urbano T
    Radiother Oncol; 2021 Jul; 160():54-60. PubMed ID: 33845044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pre-operative prognostic score for the selection of patients for salvage surgery after recurrent head and neck squamous cell carcinomas.
    Lupato V; Polesel J; La Torre FB; Fanetti G; Fratta E; Gobitti C; Baldassarre G; Vaccher E; Franchin G; Giacomarra V
    Sci Rep; 2021 Jan; 11(1):502. PubMed ID: 33436706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.